Endovascular treatment of the tricuspid valve: current status

Abstract

According to the latest studies, the surgical intervention rate of the tricuspid valve is very low, despite the large number of patients with severe tricuspid regurgitation with indication for surgery according to clinical practice guidelines. Likewise, recent data demonstrate that isolated tricuspid valve surgery is significantly and independently associated with high mortality. New transcatheter thera pies are emerging to solve these issues. In the present work, a non-systematic review of the state of the art of the different percutaneous devices currently on the market was carried out, organized into three groups: valve with implant in orthotopic or heterotopic position, annuloplasty systems and coaptation systems. Thus, this document aims to offer a global vision of the current landscape and future perspectives of endovascular treatments of tricuspid valve disease, a field of great interest in full expansion. (C) 2021 Sociedad Espanola de Cirugia Cardiovascular y Endovascular. Published by Elsevier Espana, S.L.U.